G2 Investment Partners Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-94,779
Closed -$3.51M 79
2022
Q1
$3.51M Buy
94,779
+21,854
+30% +$852K 0.83% 38
2021
Q4
$3.32M Sell
72,925
-45,964
-39% -$2.4M 0.57% 46
2021
Q3
$7.53M Sell
118,889
-22,855
-16% -$1.74M 1.31% 29
2021
Q2
$13M Sell
141,744
-18,461
-12% -$1.47M 2.14% 21
2021
Q1
$10.9M Sell
160,205
-36,482
-19% -$2.83M 1.73% 24
2020
Q4
$14.3M Buy
196,687
+148,687
+310% +$8.62M 2.62% 10
2020
Q3
$1.82M Sell
48,000
-13,047
-21% -$440K 0.44% 52
2020
Q2
$2.16M Buy
+61,047
New +$1.74M 0.51% 52
2020
Q1
Sell
-94,913
Closed -$2.05M 86
2019
Q4
$2.05M Sell
94,913
-30,456
-24% -$699K 0.66% 45
2019
Q3
$2.83M Buy
+125,369
New +$3.47M 0.81% 42
2019
Q2
Sell
-44,589
Closed -$1.41M 63
2019
Q1
$1.41M Sell
44,589
-17,500
-28% -$510K 0.43% 46
2018
Q4
$1.56M Buy
62,089
+19,089
+44% +$490K 0.65% 38
2018
Q3
$1.24M Sell
43,000
-30,400
-41% -$569K 0.45% 47
2018
Q2
$898K Sell
73,400
-65,900
-47% -$756K 0.3% 52
2018
Q1
$1.11M Buy
139,300
+89,300
+179% +$550K 0.44% 49
2017
Q4
$367K Buy
+50,000
New +$312K 0.14% 60

Other funds holding CDNA

G2 Investment Partners Management's CDNA Position: Q2 2022 in Review

G2 Investment Partners Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 94,779 shares — an estimated $3.51M sold.

G2 Investment Partners Management first reported a position in CDNA in Q4 2017 and held it in 16 quarters. The position peaked at $14.3M in Q4 2020. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • G2 Investment Partners Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • G2 Investment Partners Management sold 94,779 CareDx shares in Q2 2022, an estimated $3.51M.
  • G2 Investment Partners Management first reported a position in CareDx in Q4 2017 and held it in 16 quarters.
  • G2 Investment Partners Management's CareDx position peaked at $14.3M in Q4 2020.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on G2 Investment Partners Management's 13F filing for Q2 2022, filed 15 Aug 2022.